Graham P. Bunn – författare

The GLP regulations have been enacted since 1978 and are currently under a proposed FDA amendment to revise terminology and accommodate other changes relating to advances in technology related to the industry. This book provides a unique opportunity to access interpretation of the 21CFR58 regulatory requirements from leading industry experts with a vast knowledge and expertise in their fields. The approach used takes the regulations, provides interpretations and references to examples and regulatory actions. Data integrity and the use of electronic systems in compliance with 21CFR11 Electronic Records: Electronic Signatures are also discussed.• Unique volume covering FDA inspections of GLP facilities• Provides a detailed interpretation of GLP Regulations• Presents the latest on electronic data management in GLP• Describes GLP and computer systems validation• Can be referenced repeatedly in supporting daily hands on implementation of the CFR requirements

This book provides insight into the world of pharmaceutical quality systems and the key elements that must be in place to change the business and organizational dynamics from task-oriented procedure-based cultures to truly integrated quality business systems that are self-detecting and correcting. Chapter flow has been changed to adopt a quality systems organization approach, and supporting chapters have been updated based on current hot topics including the impact of the worldwide supply chain complexity and current regulatory trends.Key Features:Presents insight into the world of pharmaceutical quality systemsAnalyzes regulatory trends and expectationsIncludes approaches and practices used in the industry to comply with regulatory requirementsDiscusses recent worldwide supply chain issuesDelivers valuable information to a worldwide audience regarding the current GMP practices in the industry

The GLP regulations have been enacted since 1978 and are currently under a proposed FDA amendment to revise terminology and accommodate other changes relating to advances in technology related to the industry. This book provides a unique opportunity to access interpretation of the 21CFR58 regulatory requirements from leading industry experts with a vast knowledge and expertise in their fields. The approach used takes the regulations, provides interpretations and references to examples and regulatory actions. Data integrity and the use of electronic systems in compliance with 21CFR11 Electronic Records: Electronic Signatures are also discussed.• Unique volume covering FDA inspections of GLP facilities• Provides a detailed interpretation of GLP Regulations• Presents the latest on electronic data management in GLP• Describes GLP and computer systems validation• Can be referenced repeatedly in supporting daily hands on implementation of the CFR requirements

Good clinical practice (GCP) is a set of internationally recognized ethical and scientific quality requirements that must be followed when designing, conducting, recording, and reporting trials that involve the participation of human subjects. Compliance with GCP assures patients and the public that the rights, safety, and wellbeing of people taking part in studies are protected and that research data is reliable.Presents details on GCP, the international ethical, scientific, and practical standard to which all clinical research is conducted.Provides the most up‑to‑date and best practices, techniques, and methodologies in good clinical practice.Discusses applicable laws and regulations supporting GCP compliance, quality and operations.Describes who is responsible for implementing and maintaining quality assurance and quality control systems to ensure that studies are conducted and data are generated, documented, and reported in compliance with the protocol.

Good clinical practice (GCP) is a set of internationally recognized ethical and scientific quality requirements that must be followed when designing, conducting, recording, and reporting trials that involve the participation of human subjects. Compliance with GCP assures patients and the public that the rights, safety, and wellbeing of people taking part in studies are protected and that research data is reliable.Presents details on GCP, the international ethical, scientific, and practical standard to which all clinical research is conducted.Provides the most up‑to‑date and best practices, techniques, and methodologies in good clinical practice.Discusses applicable laws and regulations supporting GCP compliance, quality and operations.Describes who is responsible for implementing and maintaining quality assurance and quality control systems to ensure that studies are conducted and data are generated, documented, and reported in compliance with the protocol.

This book provides insight into the world of pharmaceutical quality systems and the key elements that must be in place to change the business and organizational dynamics from task-oriented procedure-based cultures to truly integrated quality business systems that are self-detecting and correcting. Chapter flow has been changed to adopt a quality systems organization approach, and supporting chapters have been updated based on current hot topics including the impact of the worldwide supply chain complexity and current regulatory trends.Key FeaturesPresents insight into the world of pharmaceutical quality systems.Analyzes regulatory trends and expectations.Includes approaches and practices used in the industry to comply with regulatory requirements.Discusses recent worldwide supply chain issues.Delivers valuable information to a worldwide audience regarding the current Good Manufacturing Practices in the industry.